The 2026 Over-the-Counter (OTC) research series was undertaken by Amárach Research on behalf of Azure Pharmaceuticals. It is based on a nationally representative sample of 1,000 adults in Ireland. To access our 2026 Over-the-Counter (OTC)… Read More »2026 Over-the-Counter Research Series
When the Common Conditions Scheme (CCS) was introduced earlier this year, giving pharmacists powers to prescribe treatment for eight common illnesses without patients first requiring a GP appointment, the early discussion understandably focused on the… Read More »The Common Conditions Scheme: research shows public attitudes are moving faster than many might have expected
In recent weeks, Euractiv has reported that the Swedish Medical Products Agency is seeking the creation of a state-run pharmaceutical production company in order to combat critical medicine shortages.
In recent weeks, Euractiv has reported that the Swedish Medical Products Agency is seeking the creation of a state-run pharmaceutical production company in order to combat critical medicine shortages.
In recent weeks, Euractiv has reported that the Swedish Medical Products Agency is seeking the creation of a state-run pharmaceutical production company in order to combat critical medicine shortages.
In recent weeks, Euractiv has reported that the Swedish Medical Products Agency is seeking the creation of a state-run pharmaceutical production company in order to combat critical medicine shortages.
In recent weeks, Euractiv has reported that the Swedish Medical Products Agency is seeking the creation of a state-run pharmaceutical production company in order to combat critical medicine shortages.
In recent weeks, Euractiv has reported that the Swedish Medical Products Agency is seeking the creation of a state-run pharmaceutical production company in order to combat critical medicine shortages.
Azure is delighted to announce the launch of Trazodone Hydrochloride Azure 50mg & 100 mg hard capsules.
Read More »Product launch: Trazodone
2024 has heralded a flurry of additions to the Interchangeable List marking the busiest year of additions since the first year of enactment of the Health (Pricing and Supply of Medical Goods) Act.